Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc.

IMDX | NASDAQ
Chart Builder DCF Calculator
$4.01
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$3.88
-$0.13 (-3.24%)
Pre-market: Sep 22, 2026, 4:01 AM ET

Market Data

Market Cap
$129.48M
Enterprise Value
$114.35M
Beta
1.80
Average Volume
291.62K
Shares Outstanding (Diluted)
36.75M
Shares Change YoY
14.76%
Institutional Ownership
54.86%
Exchange
NASDAQ
ISIN
US68235C2061

Price Performance

Price Change 1M
-6.7%
Price Change 3M
-25.3%
Price Change 6M
-3.1%
Price Change YTD
-44.0%
Price Change 1Y
22.6%
Price Change 3Y
25.9%
Price Change 5Y
-94.6%
1M CAGR (ann.)
-17.0%
1Y CAGR (ann.)
19.0%
5Y CAGR (ann.)
-44.5%
All-Time CAGR
-29.1%

Valuation

PE Ratio
-2.64
Forward PE
N/A
PEG Ratio
-0.03
Forward PEG
0.55
PS Ratio
77.54
Forward PS
19.30
PB Ratio
-6.08
P/FCF Ratio
-4.19
P/Adj. FCF Ratio
-3.87
P/OCF Ratio
-5.49
EV/Sales
68.47
EV/EBIT
-2.32
EV/EBITDA
-2.44
EV/FCF
-3.70
Earnings Yield
-37.9%
FCF Yield
-23.8%
Adj. FCF Yield
-25.8%

Financial Health

Net Cash
$15.13M
Total Debt
$2.63M
Cash & Short-Term Investments
$17.76M
Total Assets
$29.44M
Current Ratio
2.00
Quick Ratio
1.98
Debt / Equity Ratio
-0.12
Debt / EBITDA
-0.06
Debt / FCF
-0.09
OCF / Debt
-10.27
Interest Coverage
-436.03
Altman Z-Score
-23.31
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
11.2%
Operating Profit Margin
-2558.7%
EBITDA Margin
-2803.5%
Net Profit Margin
-2955.6%
FCF Margin
-1848.8%
Adj. FCF Margin
-2001.9%
SBC / Revenue
150.8%
SBC Impact (per share)
-8.3%

Returns

Return on Assets
-167.6%
Return on Equity
271.8%
Return on Invested Capital
-204.8%
Return on Capital Employed
-223.1%
Return on Tangible Assets
-167.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
14.9%
Revenue CAGR 5Y
-16.9%
Revenue CAGR 10Y
18.5%
EPS CAGR 3Y
44.4%
EPS CAGR 5Y
48.1%
EPS CAGR 10Y
10.8%
FCF CAGR 3Y
-28.8%
FCF CAGR 5Y
14.3%
FCF CAGR 10Y
-7.8%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.24
EPS Growth Est (next Q)
-30.5%
Revenue Est (next Q)
$215.12K
Revenue Growth Est (next Q)
-17.3%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$9.75
Price Target Upside
143.1%

Cash Flow

Operating Cash Flow
$-26.95M
Free Cash Flow
$-30.88M
Adj. Free Cash Flow
$-33.43M
FCF Per Share
-$0.84
OCF Per Share
-$0.73
OCF/S Ratio
-1614.0%

Income Statement

Revenue
$1.67M
Gross Profit
$186.5K
Operating Income
$-42.73M
EBITDA
$-46.82M
Net Income
$-49.36M
EPS (Diluted)
-$1.52
Revenue / Employee
$29.3K
Profit / Employee
$-865.95K
Employees
57

© 2026 bestshares.com. All rights reserved.